Mereo Biopharma Group Plc's total assets for Q1 2025 were $68.32M, a decrease of -10.56% from the previous quarter. MREO total liabilities were $8.24M for the fiscal quarter, a -46.56% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.